BC Asset List (196)
Dr. Galina Vorobeychik has conducted research on Multiple Sclerosis at Burnaby Hospital. Multiple Sclerosis, or MS, is a disease that affects the brain and spinal cord, resulting in a loss of muscle control, vision and s...
Dr. Ansley is a clinician scientist with 25 years experience in clinical care, research and teaching. His area of specialization is cardiac anaesthesiology. Over the past 15 years, Dr. Ansley has supervised 2 undergra...
We review all types of studies involving human research conducted by faculty, staff, and students, and any studies involving faculty, staff, or students on any of our campuses by external researchers as well. ...
The Clinical Research Ethics Board (CREB) reviews research that involves surgery, clinical interventions, exercise programs, and/or the analysis of clinical data. Activities that fall under CREB review include: the admin...
Dr. Christine H Lee is a Clinical Professor in the Department of Pathology and Laboratory Medicine at UBC’s Faculty of Medicine, and works as a researcher and medical microbiologist with Island Health. Trained in I...
Want to see full profiles?
Example:
Dr. Christine H Lee is a Clinical Professor in the Department of Pathology and Laboratory Medicine at UBC’s Faculty of Medicine, and works as a researcher and medical microbiologist with Island Health. Trained in Internal Medicine, Infectious Diseases and Medical Microbiology at the University of Toronto, her clinical and research interests include refractory and recurrent Clostridium difficile infection, antimicrobial resistant organisms, inflammatory bowel disease, and fostering appropriate lab use and best practices.
Dr. Lee has been awarded research funding from the Canadian Institutes of Health Research; the National Science and Engineering Council of Canada; and the Crohn’s and Colitis Foundation of Canada. She is also a recipient of the Michael Smith Foundation for Health Research Health Professional Investigator Award (2017). With this award, she has established the British Columbia Associated Lyophilized (LYO) Microbiota Program (BCaLM), which aims to establish the safety of lyophilized Fecal Microbiota Transplant for patients living with chronic gut disorders.
